Ausgabe 1/2011
Inhalt (21 Artikel)
Reinterpretation of evidence advanced for neo- oogenesis in mammals, in terms of a finite oocyte reserve
Elena Notarianni
Luteal blood flow in patients undergoing GnRH agonist long protocol
Akihisa Takasaki, Isao Tamura, Fumie Kizuka, Lifa Lee, Ryo Maekawa, Hiromi Asada, Toshiaki Taketani, Hiroshi Tamura, Katsunori Shimamura, Hitoshi Morioka, Norihiro Sugino
Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors
Michael J Bradaric, Animesh Barua, Krishna Penumatsa, Yu Yi, Seby L Edassery, Sameer Sharma, Jacques S Abramowicz, Janice M Bahr, Judith L Luborsky
Squamous cell carcinoma in situ arising in mature cystic teratoma of the ovary: a case report
Fatima A Zakkouri, Saloua Ouaouch, Saber Boutayeb, Mouna Rimani, Lamiae Gamra, Hind Mrabti, Hassan Errihani
Differential hRad17 expression by histologic subtype of ovarian cancer
Jennifer L Young, E Colin Koon, Joseph Kwong, William R Welch, Michael G Muto, Ross S Berkowitz, Samuel C Mok
MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells
Moorthy P Ponnusamy, Parthasarathy Seshacharyulu, ArokiaPriyanka Vaz, Parama Dey, Surinder K Batra
Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation
Mary E Sabatini, Lankai Guo, Maureen P Lynch, Joseph O Doyle, HoJoon Lee, Bo R Rueda, Aaron K Styer
On the path to translation: Highlights from the 2010 Canadian Conference on Ovarian Cancer Research
Brigitte L Thériault, Trevor G Shepherd
Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)
Clarisse S Muenyi, Vanessa A States, Joshua H Masters, Teresa W Fan, C William Helm, J Christopher States
The short form endometriosis health profile (EHP-5): translation and validation study of the Iranian version
Azita Goshtasebi, Maryam Nematollahzadeh, Fatemeh Zahra Hariri, Ali Montazeri
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
Yi Yu, Seby L Edassery, Animesh Barua, Jacques S Abramowicz, Janice M Bahr, Ingegerd Hellstrom, Judith L Luborsky
A retrospective analysis of clinicopathological and prognostic characteristics of ovarian tumors in the State of Espírito Santo, Brazil
Marcela F Paes, Renata D Daltoé, Klesia P Madeira, Lucas CD Rezende, Gabriela M Sirtoli, Alice L Herlinger, Leticia S Souza, Luciana B Coitinho, Débora Silva, Murilo F Cerri, Ana Cristina N Chiaradia, Alex A Carvalho, Ian V Silva, Leticia BA Rangel
Accuracy of 64-multidetector computed tomography in diagnosis of adnexal tumors
Fatemeh Gatreh-Samani, Mohammad Kazem Tarzamni, Elaheh Olad-Sahebmadarek, Ali Dastranj, Aimaz Afrough
Serous papillary adenocarcinoma possibly related to the presence of primitive oocyte-like cells in the adult ovarian surface epithelium: a case report
Irma Virant-Klun, Thomas Skutella, Branko Cvjeticanin, Martin Stimpfel, Jasna Sinkovec
HOX genes in ovarian cancer
Zoë L Kelly, Agnieszka Michael, Simon Butler-Manuel, Hardev S Pandha, Richard GL Morgan
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Smriti Kumar, Arooshi Kumar, Parag P Shah, Shesh N Rai, Siva K Panguluri, Sham S Kakar
Evaluation of early atherosclerotic findings in women with polycystic ovary syndrome
Afshin Mohammadi, Mohammadreza Aghasi, Leila Jodeiry-farshbaf, Shaker Salary-Lac, Mohammad Ghasemi-rad
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression
Deep Agnani, Olga Camacho-Vanegas, Catalina Camacho, Shashi Lele, Kunle Odunsi, Samantha Cohen, Peter Dottino, John A Martignetti
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
Anna Felisiak-Golabek, Alina Rembiszewska, Iwona K Rzepecka, Lukasz Szafron, Radoslaw Madry, Magdalena Murawska, Tomasz Napiorkowski, Piotr Sobiczewski, Beata Osuch, Jolanta Kupryjanczyk
Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
Cheryl A Sherman-Baust, Kevin G Becker, William H Wood III, Yongqing Zhang, Patrice J Morin
Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology
Andalib Farhat, Pascal Philibert, Charles Sultan, Francis Poulat, Brigitte Boizet-Bonhoure